highlight
male
gender
comorbid
independ
risk
factor
death
j
u
r
n
l
p
r
e
p
r
f
patient
lymphopenia
high
crp
independ
risk
factor
poor
outcom
risk
factor
would
facilit
earli
identif
highrisk
patient
abstract
background
studi
reveal
clinic
characterist
hospit
patient
howev
predict
factor
outcom
remain
unclear
object
attempt
determin
predict
factor
poor
outcom
patient
studi
design
singlecent
retrospect
studi
clinic
laboratori
treatment
data
collect
analyz
hospit
patient
laboratoryconfirm
union
hospit
gather
data
discharg
deterior
patient
compar
among
patient
patient
discharg
patient
deterior
lymphocyt
count
gl
vs
gl
lower
deterior
group
discharg
group
number
pulmonari
lobe
involv
vs
serum
creactiv
protein
crp
mgl
vs
mgl
pgml
vs
pgml
pgml
vs
pgml
concentr
deterior
patient
elev
compar
discharg
patient
multivari
logist
regress
analysi
show
male
gender
comorbid
lymphopenia
elev
crp
independ
risk
factor
poor
prognosi
patient
conclus
find
would
facilit
earli
identif
highrisk
patient
novel
envelop
rna
betacoronaviru
current
name
sever
acut
respiratori
syndrom
sinc
first
identifi
epidem
scale
recent
emerg
increas
rapidli
case
aris
across
china
countri
recent
studi
reveal
clinic
characterist
hospit
patient
huang
et
al
indic
patient
admit
icu
patient
die
among
hospit
patient
icu
patient
higher
plasma
level
proinflammatori
cytokin
wang
et
al
prove
patient
treat
icu
older
men
comorbid
dyspnea
anorexia
compar
treat
icu
among
hospit
patient
nevertheless
predict
risk
factor
poor
outcom
patient
remain
unclear
therefor
collect
data
clinic
manifest
togeth
detail
laboratori
examin
attempt
determin
predict
factor
poor
outcom
patient
laboratoryconfirm
patient
admit
union
hospit
tongji
medic
colleg
huazhong
univers
scienc
technolog
januari
februari
enrol
patient
diagnos
base
guidanc
exclud
patient
prescrib
corticosteroid
immunosuppress
j
u
r
n
l
p
r
e
p
r
f
within
day
admiss
procalcitonin
level
ugl
influenza
bacteria
fungi
infect
reveal
nasal
pharyng
swab
cultur
admiss
studi
approv
ethic
committe
union
hospit
tongji
medic
colleg
huazhong
univers
scienc
technolog
compli
principl
express
declar
helsinki
written
inform
consent
waiv
urgent
situat
retrospect
natur
ethic
commiss
total
patient
includ
medic
histori
clinic
manifest
comorbid
radiolog
assess
laboratori
find
admiss
treatment
strategi
extract
crosscheck
electron
medic
record
comorbid
includ
hypertens
cardiovascular
diseas
diabet
chronic
obstruct
pulmonari
diseas
chronic
liver
diseas
malign
number
pulmonari
lobe
involv
evalu
chest
comput
tomographi
admiss
laboratori
test
admiss
compris
complet
blood
count
liver
renal
function
creactiv
protein
crp
interleukin
il
laboratori
confirm
achiev
rtpcr
assay
conduct
accord
protocol
establish
laboratori
test
perform
use
commerci
kit
depart
clinic
laboratori
union
hospit
preliminari
assess
diseas
sever
develop
ordin
scale
clinic
statu
admiss
follow
categori
death
intens
care
unit
icu
hospit
requir
extracorpor
membran
oxygen
ecmo
andor
invas
mechan
ventil
icu
hospit
requir
ecmo
andor
invas
mechan
ventil
nonicu
hospit
requir
supplement
oxygen
nonicu
hospit
requir
j
u
r
n
l
p
r
e
p
r
f
supplement
oxygen
hospit
discharg
primari
outcom
diseas
deterior
includ
transfer
isol
ward
icu
allcaus
death
includ
patient
divid
two
group
accord
clinic
outcom
group
favor
prognosi
discharg
recoveri
group
poor
prognosi
diseas
deterior
continu
variabl
express
median
interquartil
rang
iqr
compar
mannwhitney
u
test
categor
variabl
express
number
compar
test
fisher
exact
test
discharg
deterior
group
twosid
less
consid
statist
signific
odd
ratio
poor
prognosi
patient
analyz
multivari
logist
regress
adjust
select
confound
age
gender
comorbid
bodi
temperatur
number
pulmonari
lobe
involv
leukocyt
count
neutrophil
count
lymphocyt
count
monocyt
count
alanin
aminotransferas
aspart
aminotransferas
creactiv
protein
level
level
level
admiss
analysi
upper
limit
iqr
cohort
use
cutoff
valu
age
year
crp
mgl
pgml
pgml
respect
twotail
pvalu
consid
statist
signific
analys
carri
spss
version
spss
chicago
il
usa
clinic
characterist
shown
tabl
hospit
treatment
patient
adjust
accord
patient
condit
tabl
patient
receiv
antivir
therapi
mostli
antibacteri
therapi
corticosteroid
given
case
dead
case
discharg
case
vs
deterior
patient
requir
mechan
ventil
ecmo
employ
one
sever
case
main
baselin
clinic
laboratori
characterist
crp
quartil
shown
tabl
patient
elev
crp
level
greater
proport
comorbid
dyspnea
age
lymphopenia
concentr
number
pulmonari
lobe
involv
increas
rise
crp
level
deterior
patient
divid
last
quartil
crp
level
mgl
result
multivari
logist
regress
analysi
shown
tabl
report
cohort
laboratoryconfirm
hospit
patient
cohort
patient
present
fever
cough
dyspnea
howev
upper
j
u
r
n
l
p
r
e
p
r
f
respiratori
tract
sign
gastrointestin
symptom
rare
suggest
differ
viral
tropism
compar
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
among
patient
isol
ward
baselin
patient
discharg
deterior
patient
poor
prognosi
older
male
patient
comorbid
dyspnea
higher
neutrophil
count
lower
lymphocyt
count
liver
dysfunct
increas
number
pulmonari
lobe
involv
chest
ct
imag
moreov
note
patient
poor
prognosi
also
high
amount
crp
admiss
multivari
analysi
risk
factor
male
comorbid
lymphopenia
obvious
elev
crp
signific
predictor
poor
prognosi
patient
hypertens
domin
comorbid
studi
proport
patient
hypertens
significantli
increas
poor
prognosi
molecular
model
reveal
receptor
bind
domain
rbd
stronger
interact
angiotensin
convert
enzym
could
upregul
ace
inhibitor
acei
blockad
angiotensin
ii
receptor
arb
liver
heart
thu
increas
entri
coronavirus
host
cell
might
found
patient
complic
hypertens
take
acei
arb
result
poor
prognosi
lymphopenia
common
featur
coronaviru
infect
lymphocyt
apoptosi
directli
induc
coronavirus
might
major
caus
lymphopenia
yang
et
al
observ
sar
patient
improv
lymphocyt
count
gradual
return
j
u
r
n
l
p
r
e
p
r
f
normal
rang
thu
lymphopenia
tempor
associ
diseas
sever
besid
direct
attack
viru
progress
inflammatori
injuri
suggest
possibl
mechan
crp
downstream
acut
phase
protein
innat
immun
respons
produc
increas
synthesi
proinflammatori
cytokin
activ
immun
respons
therefor
serum
crp
level
often
use
laboratori
marker
inflamm
studi
indic
crp
predict
factor
diseas
progress
merscovand
patient
studi
first
report
crp
could
also
predictor
progress
use
treatment
patient
sever
ill
reduc
inflammatoryinduc
lung
injuri
howev
current
evid
patient
sar
mer
suggest
signific
effect
corticosteroid
mortal
differ
extens
antiinflammatori
effect
corticosteroid
drug
specif
axi
might
show
advantag
thu
crp
might
predictor
poor
prognosi
also
indic
antiinflammatori
therapi
limit
studi
first
singl
center
studi
small
sampl
size
ci
rel
larg
second
retrospect
studi
result
need
verifi
prospect
studi
third
aim
studi
risk
factor
prognosi
sampl
size
poor
prognosi
group
small
moreov
unabl
analyz
differ
clinic
characterist
patient
poor
j
u
r
n
l
p
r
e
p
r
f
prognosi
group
due
small
sampl
size
fourth
miss
asymptomat
mild
case
manag
home
henc
cohort
might
repres
sever
popul
fifth
risk
factor
viral
load
viral
antibodi
titer
caus
death
avail
studi
sixth
treatment
patient
clinic
driven
unifi
standard
conclus
male
gender
comorbid
lymphopenia
elev
crp
risk
factor
poor
prognosi
patient
find
would
facilit
earli
identif
highrisk
patient
especi
primari
hospit
tang
full
access
data
studi
take
respons
integr
data
accuraci
data
analysi
studi
concept
design
tang
zhang
yu
acquisit
analysi
interpret
data
tang
zhang
yu
liu
tong
draft
manuscript
tang
yu
zhang
critic
revis
manuscript
import
intellectu
content
author
administr
technic
materi
support
tang
yu
zhang
tong
studi
supervis
tang
fund
statement
research
receiv
specif
grant
fund
agenc
public
commerci
notforprofit
sector
j
u
r
n
l
p
r
e
p
r
f
p
valu
indic
differ
discharg
dead
patient
p
consid
statist
signific
p
valu
indic
differ
discharg
dead
patient
p
consid
statist
signific
j
u
r
n
l
p
r
e
p
r
f
j
u
r
n
l
p
r
e
p
r
f
chronic
hepat
cancer
lymphopenia
leukocyt
count
less
gl
elev
crp
creactiv
protein
mgl
ci
confid
interv
odd
ratio
crp
creactiv
protein
data
calcul
logist
regress
adjust
age
gender
comorbid
bodi
temperatur
number
pulmonari
lobe
involv
leukocyt
count
neutrophil
count
lymphocyt
count
monocyt
count
alanin
aminotransferas
aspart
aminotransferas
creactiv
protein
level
admiss
